Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crofelemer safety in HIV-positive subjects with diarrhea
NCT01374490Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of crofelemer in HIV-associated diarrhea, sponsored by Valeant Pharmaceuticals. Started Jun 2011; status: completed.
02
Drugs
crofelemer
03
Conditions
HIV-associated diarrhea
Beyond the preview
Go deeper on NCT01374490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374490.